Despite being considered the standard surgical procedure for symptomatic cervical disc disease, anterior cervical decompression and fusion invariably accelerates adjacent segment degeneration. Cervical total disc replacement is a motion-preserving procedure developed as a substitute to fusion. Whether cervical total disc replacement is superior to fusion remains unclear.
We comprehensively searched PubMed, EMBASE, Medline, and the Cochrane Library in accordance with the inclusion criteria to identify possible studies. The retrieved results were last updated on December 12, 2014. We classified the studies as short-term and midterm follow-up.
Nineteen randomized controlled trials involving 4516 cases were identified. Compared with anterior cervical decompression and fusion, cervical total disc replacement had better functional outcomes (neck disability index [NDI], NDI success, neurological success, neck pain scores reported on a numerical rating scale [NRS], visual analog scales scores and overall success), greater segmental motion at the index level, fewer adverse events and fewer secondary surgical procedures at the index and adjacent levels in short-term follow-up (P < 0.05). With midterm follow-up, the cervical total disc replacement group indicated superiority in the NDI, neurological success, pain assessment (NRS), and secondary surgical procedures at the index level (P < 0.05). The Short Form 36 (SF-36) and segmental motion at the adjacent level in the short-term follow-up showed no significant difference between the two procedures, as did the secondary surgical procedure rates at the adjacent level with midterm follow-up (P > 0.05).
Cervical total disc replacement presented favorable functional outcomes, fewer adverse events, and fewer secondary surgical procedures. The efficacy and safety of cervical total disc replacement are superior to those of fusion. Longer-term, multicenter studies are required for a better evaluation of the long-term efficacy and safety of the two procedures.
Citation: Zhang Y, Liang C, Tao Y, Zhou X, Li H, Li F, et al. (2015) Cervical Total Disc Replacement is Superior to Anterior Cervical Decompression and Fusion: A Meta-Analysis of Prospective Randomized Controlled Trials. PLoS ONE 10(3): e0117826. https://doi.org/10.1371/journal.pone.0117826
Academic Editor: Mohammed Shamji, Toronto Western Hospital, CANADA
Received: November 15, 2014; Accepted: December 30, 2014; Published: March 30, 2015
Copyright: © 2015 Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: This study was partly supported by a grant from the National Nature Science Foundation of China (81401822 and 81171756), and the key Science and Technology Planning Project (2012C13G2010083) and (2012C33121) and Nature Science Foundation (Q14H060007 and Y13H060001) of ZhejiangProvince (http://www.nsfc.gov.cn/, http://www.zjnsf.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Anterior cervical decompression and fusion (ACDF) is generally considered the standard surgical procedure for cervical myelopathy or radiculopathy with degenerative disc disease [1,2]. ACDF typically consists of decompression, grafting and plate fixation . Compared to other spinal procedures, ACDF demonstrates higher success rates, including more favorable outcomes and relief of symptoms . Complications invariably occur with this procedure. Pseudarthrosis and junctional degeneration, commonly known as adjacent segment disease, are the most notable complications, which is explained by bio-mechanical studies which indicate that adjacent levels of cervical fusion present higher intradiscal pressures and increased segmental motion [5–7]. In recent decades, data have shown that as a consequence of fusion surgery, the incidence of adjacent segment degeneration varies from 3% to 8% annually, and approximately 25% of the patients would present with clinically significant adjacent segment disease within 10 years after the initial surgery [6,8,9].
Cervical total disc replacement (CTDR) is a relatively new motion-preserving procedure that has been regarded as a substitute for ACDF [10–12]. The function of CTDR in motion preservation of the adjacent segment remains controversial. Additionally, the incidence of heterotopic ossification and the effect on adjacent-level disease resulting from CTDR are disputed in clinical studies [13,14]. To address these issues, we collected prospective evidence and performed a meta-analysis to compare the efficacy and safety of CTDR and ACDF for the treatment of symptomatic cervical disc disease.
Materials and Methods
Search Strategy and Criteria
Two independent reviewers (YJZ and CZL) systematically searched electronic databases (PubMed, EMBASE, Medline, and the Cochrane Library) with a limit of ‘‘clinical trial”. The retrieved results were last updated on December 12, 2014. We used the following terms and Boolean operators: ‘‘(Anterior cervical decompression and fusion OR anterior cervical arthrodesis OR ACDF OR fusion) AND (Artificial cervical disc replacement OR CTDR OR Cervical arthroplasty OR disc implants OR disc prostheses OR CDA)”. We included studies that met the following criteria: (1) the target patients had symptomatic cervical disc disease and underwent CTDR or ACDF; (2) the patients were older than 18 years; (3) postoperative follow-up extended at least 2 years for the included patients; (4) the outcomes included at least one of the following conditions: 1) neck disability index (NDI); 2) NDI success; 3) neck and arm pain assessments measured by visual analog scales (VAS) or the numerical rating scale (NRS); 4) Short Form 36(SF-36) mental or physical health surveys (physical component summary or mental component summary scores); 5) Neurological status; 6) flexion-extension ROM at the index and adjacent levels; 7) secondary surgical procedures; 8) adverse events; 9) overall success; (5) the trial was a randomized controlled trial (RCT). Trials were excluded according to the following criteria: (1) the articles were observational studies, case reports, or reviews; (2) the outcomes were graphic without numerical values; (3) the same data had been published previously; (4) the RCTs had a follow-up of less than 2 years.
For each eligible trial, the elements of the data, including the study design, intervention protocol, sample size, demographic data (age, gender distribution), trial duration, follow-up times, trial outcomes and loss to follow-up, were independently extracted by two reviewers (YJZ and CZL). If any disagreements existed, a third reviewer (YQT) was involved in the discussion until consensus was reached.
Two reviewers (YJZ and CZL) independently evaluated the methodological quality of the included trials in accordance with a 12-item scale recommended by the Cochrane Back Review Group . If at least six of the 12 criteria, including randomization, allocation concealment, blinding (of the patients, assessors, and surgeons), similar baseline, selective reporting, loss to follow-up, patient compliance, similar timing and intention-to-treat (ITT) analysis, were met without serious flaws, the studies were rated as having ‘‘low risk of bias”. Otherwise, the studies were rated as having ‘‘high risk of bias”. Additionally, the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach was used to evaluate the strength of evidence . Based on parameters such as study design, precision, directness, consistency and risk of bias, the quality assessment was classified as very low, low, moderate or high.
The odds ratio (OR) and the corresponding 95% confidence interval (CI) were assessed for the dichotomous outcomes, and the standardized mean difference (SMD) and 95% CI were assessed for the continuous outcomes. The chi-square test and Higgin’s I2 test were used to evaluate the heterogeneity. A p value less than 0.10 for the chi-square test or I2 values exceeding 50% indicated substantial heterogeneity. A fixed-effect model was used if significantly statistical heterogeneity was absent; otherwise, a random-effect model was applied. Because of the limited number of included studies, we did not assess the possibility of publishing bias. We used Review Manager Software (RevMan Version 5.2, The Cochrane Collaboration, Copenhagen, Denmark) to conduct the statistical analysis.
As shown in Fig. 1, the literature search initially yielded 391 relevant trials from PubMed (N = 115), EMBASE (N = 31), Medline (N = 119), and the Cochrane Library (N = 126). After duplicates were excluded, 175 trials were retained. We (YJZ and CZL) reviewed the titles and abstracts of all 175 trials. Of those studies, 108 trials were excluded because they failed to meet the inclusion criteria. The remaining 67 studies underwent a full text review. Finally, nineteen RCTs with 4516 cases were included. The follow-up times were classified as short-term (2 or 3 years) or medium-term (4 or 5 years). We recorded the characteristics of the nineteen included trials (Table 1), as well as the details of the clinical outcome measurement (Table 2).
According to the quality assessment criteria recommended by the Cochrane Back Review Group, eighteen studies with ‘‘low risk of bias” and one study with ‘‘high risk of bias” were found (Fig. 2). According to GRADE, a majority of the trials reviewed in our meta-analysis were moderate-quality studies (Tables 3 and 4).
Neck Disability Index (NDI)
With short-term follow-up, the CTDR group had statistically lower NDI scores (SMD, -0.34; 95% CI: -0.68 to 0.00, P = 0.05) than the ACDF group. However, there existed a substantial heterogeneity. Then we conducted sensitivity analysis and the result also showed that CTDR group had better NDI scores (SMD, -0.13; 95% CI: -0.25 to -0.02, P = 0.02) compared with ACDF group (Fig. 3). Additionally, we did subgroup analysis stratified by different types of prostheses. CTDR with Bryan had no significant difference compared with ACDF (SMD, -0.15; 95% CI: -0.32 to 0.02, P = 0.09). And CTDR with Prestige ST presented significantly lower NDI than ACDF (SMD, -0.20; 95% CI: -0.39 to -0.01, P = 0.04) (Table 5). With midterm follow-up, the NDI scores in the CTDR group were lower than those of the ACDF group (SMD, -0.31; 95% CI: -0.47 to -0.15, P = 0.0002) (Fig. 3).
IV = inverse variance, CI = confidence interval, and df = degrees of freedom.
Neck Disability Index (NDI) success
NDI success was defined as a ≥15-point improvement in the NDI scores after surgery, which is generally regarded as a measure of function recovery . Five studies with short-term follow-up provided NDI success data. As shown in Fig. 4, the CTDR group had a statistically higher NDI success rate than the ACDF group (OR, 0.72; 95% CI: 0.54 to 0.95, P = 0.02).
MH = Mantel-Haenszel, CI = confidence interval, and df = degrees of freedom.
Maintenance or improvement of each neurological parameters (motor, sensory and reflexes) in standardized neurological examinations was interpreted as neurological success . With short-term follow-up, there was a statistically higher neurological success rate in the CTDR group than in the ACDF group (OR, 0.62; 95% CI: 0.45 to 0.85, P = 0.003). With midterm follow-up, two studies provided neurological success data. Additionally, we found that more patients in the CTDR group achieved neurological success than in the ACDF group (OR, 0.55; 95% CI: 0.30 to 1.01, P = 0.05) (Fig. 5).
MH = Mantel-Haenszel, CI = confidence interval, and df = degrees of freedom.
Neck and arm pain
Neck and arm pain was measured using numerical rating scales or visual analog scales. Three studies with short-term follow up used numerical rating scales to measure neck and arm pain. Compared with the ACDF group, the CTDR group had significantly lower neck pain scores (SMD, -0.14; 95% CI: -0.27 to -0.01, P = 0.04). The arm pain scores did not differ significantly between the groups (SMD, -0.04; 95% CI: -0.17 to 0.09, P = 0.56). Three studies used visual analog scales to measure neck and arm pain. The CTDR group had significantly lower neck pain scores (SMD, -1.28; 95% CI: -2.16 to 0.40, P = 0.004) and significantly lower arm pain scores (SMD, -1.03; 95% CI: -1.86 to -0.19, P = 0.02) than the ACDF group. Two studies with midterm follow-up used NRS scores. The CTDR group presented significantly lower neck pain scores (SMD, -0.28; 95% CI: -0.44 to -0.12, P = 0.0008) and significantly lower arm pain scores (SMD, -0.19; 95% CI: -0.35 to -0.03, P = 0.02) (Table 5).
The SF-36 test is a self-administered questionnaire to assess general health status; it consists of a physical component summary (PCS) score and a mental component summary (MCS) score . Three short-term follow-up studies provided PCS scores, and two of these studies provided MCS scores as well. As shown in table 5, no significant differences in the PCS scores (SMD, -0.07; 95% CI: -0.20 to 0.06, P = 0.28) and MCS scores (SMD, 0.05; 95% CI: -0.13 to 0.22, P = 0.62) were observed between the CTDR group and the ACDF group.
Range of Motion (ROM)
The segmental motions were calculated from the angular motion on lateral flexion and extension radiographs of the cervical spine . Five short-term follow-up studies provided ROM data at the index level. The CTDR group presented statistically better range of motion at the index level compared with the ACDF group (SMD, -5.20; 95% CI: -6.77 to -3.62, P < 0.00001). Two short-term follow-up studies provided ROM data at the adjacent level. No significant differences in ROM at the superior adjacent level (SMD, 0.42; 95% CI: -0.28 to 1.12, P = 0.24) or the inferior adjacent level (SMD, -0.90; 95% CI: -1.84 to 0.04, P = 0.06) were found (Table 5).
Eight studies that included a short-term follow-up investigated adverse events. We found that adverse events occurred more frequently in the ACDF group than in the CTDR group (OR, 0.58; 95% CI: 0.43 to 0.80, P = 0.0007) (Fig. 6). One study  with 74 patients had valid data for midterm follow-up.
MH = Mantel-Haenszel, CI = confidence interval, and df = degrees of freedom.
Secondary surgical procedures
Secondary surgical procedures were defined as any hardware removal, revisions, supplemental fixations, and reoperations . They were typically used to resolve persistent neck or shoulder pain, dysphagia, prosthesis flexibility or adjacent level degeneration. For the short-term follow-up studies, we analyzed secondary surgical procedures at the index level and the adjacent level. We found that the CTDR group had significantly fewer secondary surgical procedures at the index (OR, 0.32; 95% CI: 0.19 to 0.53, P < 0.00001) and the adjacent level (OR, 0.28; 95% CI: 0.11 to 0.72, P = 0.008). For the studies with midterm follow-up, the rate of secondary surgical procedures at the adjacent level (OR, 0.76; 95% CI: 0.47 to 1.22, P = 0.25) was not significantly different between the groups. We noted significantly fewer secondary surgical procedures related to the index level in the CTDR group (OR, 0.45; 95% CI: 0.29 to 0.68, P = 0.0002) (Fig. 7).
MH = Mantel-Haenszel, CI = confidence interval, and df = degrees of freedom.
If a patient achieved all of the following items, the treatment was considered an overall success: NDI success, Neurological success, an absence of serious adverse events associated with the implant or procedure and without a secondary surgery or intervention . Serious adverse events were defined as grade 3 or 4 adverse events based on the WHO criteria . Six studies provided data on the overall success, and five of those had short-term follow-ups. One study with 463 patients focused on midterm follow-up . The CTDR group presented a significantly higher overall success rate in studies with short-term (OR, 0.59; 95% CI: 0.48 to 0.74, P < 0.00001) and midterm follow-up (P = 0.004) (Fig. 8).
MH = Mantel-Haenszel, CI = confidence interval, and df = degrees of freedom.
Most clinical data have supported CTDR as a viable alternative to ACDF. Several recent reports [13,14] have indicated that CTDR is not better than fusion in relieving symptoms associated with disc degeneration in the cervical spine. The comparison between CTDR and fusion was conducted in a few meta-analyses. With a total of eight RCTs, Yu et al.  reported CTDR was more effective than fusion in overall success rate and overall reoperation rate. Nevertheless, due to limited number of trials and the sample size, it was impractical to draw a conclusion that the patients with CTDR had better clinical status than those with fusion. Verma et al.  reported no significant difference in the rate of ASD between CTDR and fusion. However, this study only used the reoperation rate, without radiographical assessments, to evaluate the rate of ASD. It also might have a bias due to lower dropout rate in the CTDR group than fusion group. The meta-analysis conducted by Yin et al.  reported better function and lower complications in the patients with CTDR compared with the patients with fusion. Our results were consistent with this study, but they did not exclude the RCTs with one year follow-up. And more stringent scores, such as overall success, were not utilized in their study. Overall, the efficacy and safety of CTDR procedures are still controversial. Moreover, most relevant meta-analyses [14,21–23] only chose the RCTs published before 2012, whereas several latest RCTs were reported in the last two years. We performed a meta-analysis of nineteen RCTs to determine whether CTDR was superior to ACDF.
This meta-analysis showed that patients treated with CTDR had better NDI improvement and higher NDI success rates than those treated with ACDF in short-term and midterm follow-up. However, in the subgroup analysis of NDI, CTDR with Bryan had no significant difference compared with ACDF, while CTDR with Prestige ST presented significantly lower NDI than ACDF. The result indicated that different types of prosthesis might have different efficacy and safety. Due to limited number of included articles, the other outcomes cannot be performed subgroup analyses stratified by types of prostheses. In addition to superior NDI outcomes, higher neurological success rates were reported in the CTDR group than in the fusion group. Regarding pain relief, we found that the CTDR group had lower neck pain (NRS) scores in short-term follow-up and lower neck and arm pain (NRS) scores in the midterm follow-up. Additionally, the neck and arm pain (VAS) scores in short-term follow-up also demonstrated the CTDR group had a favorable outcome. Overall, the CTDR group showed better functional improvement than the fusion group.
Compared with fusion, CTDR resulted in better segmental motion at the index level, which was consistent with the results of previous studies [24,25]. As demonstrated in previous studies, impaired ROM at the index level was normally in compensation at the adjacent levels in spinal procedures. Worse segmental motion at the index level would result in a higher load and intradiscal pressure on the adjacent segments, which would accelerate the degeneration of the adjacent segments. Eck JC et al.  explained that high intradiscal pressure led to an accumulation of waste products in the disc, which could cause cell death and disrupt metabolism. To avoid detrimental non-physiological loading exertion on the adjacent segments, researchers have focused their attention on developing CTDR to maintain the basic motion of intervertebral segments . The assumption that adjacent segment disease arises from spinal fusion with iatrogenic motion restriction is under debate. Some investigators have hypothesized that adjacent segment disease signifies progression of the natural history of spinal segmental degeneration [26,27]. The pooled results of this analysis indicated that although CTDR could retain segmental motion at the index level more effectively than fusion, the ROMs at the superior adjacent and inferior adjacent level were not statistically different. On the other hand, our data indicated that the CTDR group had significantly fewer secondary surgical procedures attributable to adjacent segment degeneration in the short-term follow-up. Hence, we hypothesized that some other factors influenced the incidence of adjacent segment degeneration. Nunley and colleagues  considered that bone mineral density and presence of concurrent lumbar degeneration had a significant effect in the incidence of adjacent segment degeneration.
In addition to fewer secondary surgical procedures, the CTDR group also had fewer adverse events. The most frequent adverse events of CTDR include heterotopic ossification, segmental kyphosis, migration, or subsidence of the artificial disc. Previous generations of CTDR were typically associated with high adverse events rates. For instance, the Bristol–Cummins joint was very efficient in maintaining motion; however, it is always complicated by joint subluxation, screw failure and high rates of dysphagia . As technology has progressed, increasing numbers of new models have been developed, including the Bryan, Prestige ST, and ProDisc-C. The Bryan prosthesis consists of a polyurethane nucleus in a saline solution bath sandwiched between two titanium alloy surfaces. And the device allows for bone ingrowth from the vertebral end plates . The Prestige ST prosthesis is a dynamic stainless steel device that consists of two metal plates, and the device permits segmental spinal motion through a ball-and-trough mechanism and maintains disc space height . The ProDisc-C prosthesis is composed of two cobalt chromium molybdenum alloy end plates with midline keels and an ultrahigh–molecular weight polyethylene (UHMWPE) inlay. The midline keel on the vertebral surfaces provides fixation while a plasma-spray titanium coating encourages bony on-growth for longer term stability . Those prostheses have advantages over previous models in retaining segmental motion, disc height and lordosis. Additionally, they have longer-term durability and produce less inflammatory reaction or osteolysis. Therefore, they can better mimic a natural intervertebral disc and, consequently, can obtain better clinical outcomes with fewer prosthesis-related complications . For fusion surgery, the most frequent adverse events include dysphagia, dural injury, hoarseness, worsening of neurological symptoms, and graft extrusion. Dysphagia was reported to be the most common complication, occurring in 3.3% of patients, whereas the overall ACDF-related complication rate was 8.4% . CTDR could substantially decrease the incidence of dysphagia to a greater degree than fusion because the CTDR procedure demands less esophageal retraction and consequently reduces the intraesophageal pressure .
Overall success is measured by a composite score that includes NDI success, neurological status, adverse events, and subsequent surgery. The composite definition of success was significantly more stringent than the traditional definition because the procedure would be considered a failure even if a patient failed only one component . In this meta-analysis, the CTDR group had a higher overall success rate than the fusion group. We hypothesized that the unique advantages of the prostheses might explain the better overall success in the CTDR group than in the ACDF group. Additional effort is required to develop novel prostheses that mimic natural intervertebral discs more closely. Innovative 3D-printing technology may provide a possible solution for this issue [33–35].
Recently, several non-RCTs were published to evaluate the long-term efficacy and safety of CTDR. Malham et al.  reported CTDR had a pretty good improvement in functional outcomes, as well as 37% of heterotopic ossification and 21% of radiographic adjacent segment disease, with average follow-up of 7.7 years. Zhang et al.  also reported CTDR had satisfactory functional outcomes without any significant complication. In this study, mean ROM at index levels is 8.6°±0.2°and 81.3% of the segments were mobile at 6 years, which indicated that ROM was preserved at index levels. In a word, the long-term studies displayed favorable efficacy and safety of CTDR, which was consistent with our meta-analysis.
The validity of the study results was limited by several factors. First, several studies presented low quality evidence resulting from inadequate blinding, insufficient allocation concealment, and imprecision. Second, missing information such as the absence of ITT analysis and loss to follow-up led to incomplete data and potentially biased results. Third, a non-inferiority study design was utilized in almost all the RCTs, and this design is typically less stringent in demonstrating efficacy than standard clinical trials. Fourth, we did not assess publication bias because of the small sample sizes, which led to imprecision across the studies. Fifth, no data on long-term efficacy and safety were available because the follow-up was no more than five years in all the included studies.
This meta-analysis indicated that in efficacy and safety, CTDR was superior to ACDF. Longer-term, multicenter studies are required for a better evaluation of the long-term efficacy and safety of these two procedures.
S1 Table. Excluded Papers.
Conceived and designed the experiments: QXC YJZ. Performed the experiments: YJZ CZL YQT. Analyzed the data: YJZ CZL. Contributed reagents/materials/analysis tools: HL XPZ FCL. Wrote the paper: YJZ.
- 1. Rao RD, Currier BL, Albert TJ, Bono CM, Marawar SV, et al. (2007) Degenerative cervical spondylosis: clinical syndromes, pathogenesis, and management. J Bone Joint Surg Am 89: 1360–1378. pmid:17575617
- 2. Buchowski JM, Anderson PA, Sekhon L, Riew KD (2009) Cervical disc arthroplasty compared with arthrodesis for the treatment of myelopathy. Surgical technique. J Bone Joint Surg Am 91 Suppl 2: 223–232.
- 3. Delamarter RB, Zigler J (2013) Five-year reoperation rates, cervical total disc replacement versus fusion, results of a prospective randomized clinical trial. Spine (Phila Pa 1976) 38: 711–717.
- 4. Palit M, Schofferman J, Goldthwaite N, Reynolds J, Kerner M, et al. (1999) Anterior discectomy and fusion for the management of neck pain. Spine (Phila Pa 1976) 24: 2224–2228. pmid:10562988
Nanda A, Sharma M, Sonig A, Ambekar S, Bollam P (2013) Surgical Complications of Anterior Cervical Diskectomy and Fusion for Cervical Degenerative Disk Disease: A Single Surgeon’s Experience of 1576 Patients. World Neurosurg.
- 6. Hilibrand AS, Carlson GD, Palumbo MA, Jones PK, Bohlman HH (1999) Radiculopathy and myelopathy at segments adjacent to the site of a previous anterior cervical arthrodesis. Journal of Bone and Joint Surgery-American Volume 81A: 519–528.
- 7. Eck JC, Humphreys SC, Lim TH, Jeong ST, Kim JG, et al. (2002) Biomechanical study on the effect of cervical spine fusion on adjacent-level intradiscal pressure and segmental motion. Spine (Phila Pa 1976) 27: 2431–2434. pmid:12435970
- 8. Yue WM, Brodner W, Highland TR (2005) Long-term results after anterior cervical discectomy and fusion with allograft and plating: a 5- to 11-year radiologic and clinical follow-up study. Spine (Phila Pa 1976) 30: 2138–2144.
- 9. Robertson JT, Papadopoulos SM, Traynelis VC (2005) Assessment of adjacent-segment disease in patients treated with cervical fusion or arthroplasty: a prospective 2-year study. Journal of Neurosurgery-Spine 3: 417–423. pmid:16381202
- 10. Anakwenze OA, Auerbach JD, Milby AH, Lonner BS, Balderston RA (2009) Sagittal cervical alignment after cervical disc arthroplasty and anterior cervical discectomy and fusion: results of a prospective, randomized, controlled trial. Spine (Phila Pa 1976) 34: 2001–2007.
- 11. Phillips FM, Lee JY, Geisler FH, Cappuccino A, Chaput CD, et al. (2013) A prospective, randomized, controlled clinical investigation comparing PCM cervical disc arthroplasty with anterior cervical discectomy and fusion. 2-year results from the US FDA IDE clinical trial. Spine (Phila Pa 1976) 38: E907–918.
- 12. Cason GW, Herkowitz HN (2013) Cervical Intervertebral Disc Replacement. Journal of Bone and Joint Surgery-American Volume 95A: 279–285.
- 13. Bartels RHMA, Donk R, Verbeek ALM (2010) No Justification for Cervical Disk Prostheses in Clinical Practice: A Meta-Analysis of Randomized Controlled Trials. Neurosurgery 66: 1153–1160. pmid:20421840
- 14. Zechmeister I, Winkler R, Mad P (2011) Artificial total disc replacement versus fusion for the cervical spine: a systematic review. European Spine Journal 20: 177–184. pmid:20936484
- 15. Furlan AD, Pennick V, Bombardier C, van Tulder M, Editorial Board CBRG (2009) 2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine (Phila Pa 1976) 34: 1929–1941.
- 16. Atkins D, Briss PA, Eccles M, Flottorp S, Guyatt GH, et al. (2005) Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system. BMC Health Serv Res 5: 25. pmid:15788089
- 17. Sasso RC, Anderson PA, Riew KD, Heller JG (2011) Results of cervical arthroplasty compared with anterior discectomy and fusion: four-year clinical outcomes in a prospective, randomized controlled trial. J Bone Joint Surg Am 93: 1684–1692. pmid:21938372
- 18. Burkus JK, Haid RW, Traynelis VC, Mummaneni PV (2010) Long-term clinical and radiographic outcomes of cervical disc replacement with the Prestige disc: results from a prospective randomized controlled clinical trial. J Neurosurg Spine 13: 308–318. pmid:20809722
- 19. Coric D, Kim PK, Clemente JD, Boltes MO, Nussbaum M, et al. (2013) Prospective randomized study of cervical arthroplasty and anterior cervical discectomy and fusion with long-term follow-up: results in 74 patients from a single site. J Neurosurg Spine 18: 36–42. pmid:23140129
World Health Organization. (1979) WHO handbook for reporting results of cancer treatment. Geneva Albany, N.Y.: World Health Organization; sold by WHO Publications Centre USA. 45 p. p.
- 21. Yu L, Song Y, Yang X, Lv C (2011) Systematic review and meta-analysis of randomized controlled trials: comparison of total disk replacement with anterior cervical decompression and fusion. Orthopedics 34: e651–658. pmid:21956061
- 22. Verma K, Gandhi SD, Maltenfort M, Albert TJ, Hilibrand AS, et al. (2013) Rate of adjacent segment disease in cervical disc arthroplasty versus single-level fusion: meta-analysis of prospective studies. Spine (Phila Pa 1976) 38: 2253–2257.
- 23. Yin S, Yu X, Zhou SL, Yin ZH, Qiu YS (2013) Is Cervical Disc Arthroplasty Superior to Fusion for Treatment of Symptomatic Cervical Disc Disease? A Meta-Analysis. Clinical Orthopaedics and Related Research 471: 1904–1919. pmid:23389804
- 24. Gao Y, Liu M, Li T, Huang F, Tang T, et al. (2013) A meta-analysis comparing the results of cervical disc arthroplasty with anterior cervical discectomy and fusion (ACDF) for the treatment of symptomatic cervical disc disease. J Bone Joint Surg Am 95: 555–561. pmid:23515991
- 25. Virk SS, Niedermeier S, Yu E, Khan SN (2014) Adjacent segment disease. Orthopedics 37: 547–555. pmid:25102498
- 26. Nunley PD, Jawahar A, Kerr EJ, Gordon CJ, Cavanaugh DA, et al. (2012) Factors Affecting the Incidence of Symptomatic Adjacent-Level Disease in Cervical Spine After Total Disc Arthroplasty 2- to 4-Year Follow-up of 3 Prospective Randomized Trials. Spine 37: 445–451. pmid:21587111
- 27. Hilibrand AS, Robbins M (2004) Adjacent segment degeneration and adjacent segment disease: the consequences of spinal fusion? Spine J 4: 190S–194S. pmid:15541666
- 28. Pickett GE, Sekhon LH, Sears WR, Duggal N (2006) Complications with cervical arthroplasty. J Neurosurg Spine 4: 98–105. pmid:16506475
- 29. Riina J, Patel A, Dietz JW, Hoskins JS, Trammell TR, et al. (2008) Comparison of single-level cervical fusion and a metal-on-metal cervical disc replacement device. Am J Orthop (Belle Mead NJ) 37: E71–77.
- 30. Murrey D, Janssen M, Delamarter R, Goldstein J, Zigler J, et al. (2009) Results of the prospective, randomized, controlled multicenter Food and Drug Administration investigational device exemption study of the ProDisc-C total disc replacement versus anterior discectomy and fusion for the treatment of 1-level symptomatic cervical disc disease. Spine J 9: 275–286. pmid:18774751
- 31. McAfee PC, Cappuccino A, Cunningham BW, Devine JG, Phillips FM, et al. (2010) Lower incidence of dysphagia with cervical arthroplasty compared with ACDF in a prospective randomized clinical trial. J Spinal Disord Tech 23: 1–8. pmid:20051917
- 32. McAfee PC, Reah C, Gilder K, Eisermann L, Cunningham B (2012) A meta-analysis of comparative outcomes following cervical arthroplasty or anterior cervical fusion: results from 4 prospective multicenter randomized clinical trials and up to 1226 patients. Spine (Phila Pa 1976) 37: 943–952.
- 33. Villar G, Graham AD, Bayley H (2013) A tissue-like printed material. Science 340: 48–52. pmid:23559243
- 34. Murphy SV, Atala A (2014) 3D bioprinting of tissues and organs. Nat Biotechnol 32: 773–785. pmid:25093879
- 35. Grunert P, Gebhard HH, Bowles RD, James AR, Potter HG, et al. (2014) Tissue-engineered intervertebral discs: MRI results and histology in the rodent spine. J Neurosurg Spine 20: 443–451. pmid:24527831
- 36. Malham GM, Parker RM, Ellis NJ, Chan PG, Varma D (2014) Cervical artificial disc replacement with ProDisc-C: clinical and radiographic outcomes with long-term follow-up. J Clin Neurosci 21: 949–953. pmid:24417795
- 37. Zhang Z, Zhu W, Zhu L, Du Y (2014) Midterm outcomes of total cervical total disc replacement with Bryan prosthesis. Eur J Orthop Surg Traumatol 24 Suppl 1: S275–281.
- 38. Heller JG, Sasso RC, Papadopoulos SM, Anderson PA, Fessler RG, et al. (2009) Comparison of BRYAN cervical disc arthroplasty with anterior cervical decompression and fusion: clinical and radiographic results of a randomized, controlled, clinical trial. Spine (Phila Pa 1976) 34: 101–107.
- 39. Cheng L, Nie L, Li M, Huo Y, Pan X (2011) Superiority of the Bryan((R)) disc prosthesis for cervical myelopathy: a randomized study with 3-year followup. Clin Orthop Relat Res 469: 3408–3414. pmid:21997779
- 40. Mummaneni PV, Burkus JK, Haid RW, Traynelis VC, Zdeblick TA (2007) Clinical and radiographic analysis of cervical disc arthroplasty compared with allograft fusion: a randomized controlled clinical trial. J Neurosurg Spine 6: 198–209. pmid:17355018
- 41. Coric D, Nunley PD, Guyer RD, Musante D, Carmody CN, et al. (2012) Prospective, randomized, multicenter study of cervical arthroplasty: 269 patients from the Kineflex|C artificial disc investigational device exemption study with a minimum 2-year follow-up: clinical article. Journal of neurosurgery Spine. pp. 348–358. pmid:22881039
- 42. Vaccaro A, Beutler W, Peppelman W, Marzluff JM, Highsmith J, et al. (2013) Clinical outcomes with selectively constrained SECURE-C cervical disc arthroplasty: two-year results from a prospective, randomized, controlled, multicenter investigational device exemption study. Spine (Phila Pa 1976) 38: 2227–2239.
- 43. Zigler JE, Delamarter R, Murrey D, Spivak J, Janssen M (2013) ProDisc-C and anterior cervical discectomy and fusion as surgical treatment for single-level cervical symptomatic degenerative disc disease: five-year results of a Food and Drug Administration study. Spine (Phila Pa 1976) 38: 203–209.
- 44. Zhang X, Zhang X, Chen C, Zhang Y, Wang Z, et al. (2012) Randomized, controlled, multicenter, clinical trial comparing BRYAN cervical disc arthroplasty with anterior cervical decompression and fusion in China. Spine (Phila Pa 1976) 37: 433–438.
- 45. Nabhan A, Steudel WI, Nabhan A, Pape D, Ishak B (2007) Segmental kinematics and adjacent level degeneration following disc replacement versus fusion: RCT with three years of follow-up. J Long Term Eff Med Implants 17: 229–236. pmid:19023947
- 46. Coric D, Cassis J, Carew JD, Boltes MO (2010) Prospective study of cervical arthroplasty in 98 patients involved in 1 of 3 separate investigational device exemption studies from a single investigational site with a minimum 2-year follow-up. Clinical article. J Neurosurg Spine 13: 715–721. pmid:21121748
- 47. Davis RJ, Kim KD, Hisey MS, Hoffman GA, Bae HW, et al. (2013) Cervical total disc replacement with the Mobi-C cervical artificial disc compared with anterior discectomy and fusion for treatment of 2-level symptomatic degenerative disc disease: a prospective, randomized, controlled multicenter clinical trial: clinical article. J Neurosurg Spine 19: 532–545. pmid:24010901
- 48. Davis RJ, Hoffman GA, Bae HW, Hisey MS, Rashbaum RF, et al. (2013) Cervical disc arthroplasty results in fewer secondary surgeries through 48 months compared to ACDF: Results for a prospective randomized IDE study for two-level use. Spine Journal 13: 164S–165S.
- 49. Rozankovic M, Marasanov SM, Vukic M (2014) Cervical Disc Replacement With Discover Versus Fusion In A Single Level Cervical Disc Disease: A Prospective Single Center Randomized Trial With A Minimum Two-Year Follow—Up. J Spinal Disord Tech. pmid:25551325